High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab - Concepedia

Concepedia

Publication | Closed Access

High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab

18

Citations

17

References

2016

Year

Shalini Sree Kumar, Yoko Tomita, Joe Wrin, Maressa A. Bruhn, Adam Swalling, M. Mohammed, Timothy Price, Jennifer E. Hardingham

Clinical & Translational Oncology

MedicinePoorer OutcomeColorectal CancerPathologyAnti-egfr TreatmentRadiation OncologyOncologyCell BiologyCancer Growth

References

	Year	Citations

Page 1